Arkolith/Insider Trading/TFFP/Form 4

Weisman Harlan F

DirectorTFF Pharmaceuticals, Inc. (TFFP) · full profile →Form 4 · filed May 20, 2022
Net Buying
Open-Market Buys
$38K
Open-Market Sells
$0
Net Open-Market Flow
$38K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2022Buy(P)5K$5.50$25K15K
May 18, 2022Buy(P)3K$5.12$13K10K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-22-028628) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML